HPS Pharmacies wish to give notice that Merck Sharp & Dohme is experiencing a supply interruption for Pneumovax® 23 as follows:
Pneumococcal Vaccine Polyvalent
Normal supplies are expected to resume in April 2020. Supplies of Pneumovax® 23 are still available under the National Immunisation Program (NIP) or government programs.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Merck Sharp & Dohme on 1800 642 865 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates